Jason S. Carter - Nov 21, 2025 Form 4 Insider Report for Vera Therapeutics, Inc. (VERA)

Role
Chief Legal Officer
Signature
/s/ Joseph R. Young, Attorney-in-Fact
Stock symbol
VERA
Transactions as of
Nov 21, 2025
Transactions value $
-$107,498
Form type
4
Date filed
11/25/2025, 04:05 PM
Previous filing
Nov 20, 2024
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Carter Jason S Chief Legal Officer C/O VERA THERAPEUTICS, INC., 2000 SIERRA POINT PARKWAY, SUITE 1200, BRISBANE /s/ Joseph R. Young, Attorney-in-Fact 2025-11-25 0002045094

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VERA Class A Common Stock Sale -$107K -3.86K -7.29% $27.82 49.1K Nov 21, 2025 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares sold to cover tax withholding obligations associated with the vesting of restricted stock units.
F2 The price reported is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $27.19 to $28.035, inclusive. The Reporting Person will provide upon request to the staff of the Securities and Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares sold at each separate price.